Management of complications: infections, autoimmunity, cytopenias

Fausto Rossini

doi:10.4081/hmr.v1i7.632

Abstracts

16 June 2009

Vol. 1 No. 7 (2007)

https://doi.org/10.4081/hmr.v1i7.632

Management of complications: infections, autoimmunity, cytopenias

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

PDF

214

Views

493

Downloads

Authors

Fausto Rossini

support@pagepress.org

In untreated patients or in patients treated with alkylating agents, most infections are bacterial (Haemophilus influenzae, Klebsiella pneumoniae Staphylococcus aureus, Streptococcus pneumoniae and Escherichia coli). Respiratory tract is the most frequent site of infection. Fungal and viral infections are rare and generally occur in heavily pre-treated patients; hypogammaglobulinemia and treatment-related neutropenia play a major role.